What caused the pre-market drop in IGPH.SW stock on 11 Mar 2026?

The pre-market decline in IGPH.SW stock to CHF0.0015 reflects heavy trading volume of 2,033,000 shares and continued weakness in fundamentals, including negative EPS and thin liquidity. In small healthcare microcaps, any selling or news gap can amplify moves.

How risky is trading IGPH.SW stock on SIX?

IGPH.SW stock is high risk due to a low current ratio (0.185), negative book value per share, and significant recent declines. High relative volume increases intraday volatility; position sizing and strict stops are essential for traders.

Does Meyka AI provide a price forecast for IGPH.SW stock?

Yes. Meyka AI's forecast model projects a near-term base of CHF0.0025 for IGPH.SW stock versus the current CHF0.0015, implying ~66.67% upside. Forecasts are model-based projections and not guarantees.

Should long-term investors buy IGPH.SW stock now?

Long-term investors should be cautious. IGPH.SW stock shows negative earnings, weak liquidity, and negative shareholders’ equity metrics. Consider entry only after signs of revenue growth, improved cash flow, or credible financing.

CH Stocks

25% drop IGPH.SW IGEA Pharma (SIX) pre-mkt 11 Mar 2026: CHF0.0015 heavy volume

ByDanny Kontos March 11, 2026March 11, 2026

The most active pre-market mover on SIX is IGPH.SW stock, trading at CHF0.0015 after a 25.0% slide on heavy turnover of 2,033,000 shares on 11 Mar 2026. The drop follows a gap from yesterday’s close of CHF0.0020 and leaves the market cap near CHF505,545. For traders focused on liquidity and volatility, IGPH.SW stock’s relative volume 10.48 today makes it a top short-term mover in the Swiss healthcare microcap cohort.